v3.26.1
Schedule of Gain on Deconsolidation (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Nov. 14, 2024
Dec. 31, 2025
Dec. 31, 2024
Nov. 15, 2024
Carrying Value of the NCI   $ (4,500) $ (11,800)  
Gain on deconsolidation   $ 39,307  
Exozymes Inc [Member]        
Subtotal of quoted closing price of Class A common shares 40,727     3,931
Quoted closing price of Class A common shares $ 10.36      
Fair value of warrants $ 1,327      
Fair value of equity method investment 42,054      
Carrying Value of the NCI (921)      
Carrying value of assets 4,282      
Less carrying value of former investment       $ (5,787)
Carrying value of warrants (321)      
Gain on deconsolidation $ 39,307